SEC Form 4 insider trading filings tracked in real time from EDGAR

Cote Elissa S. — Chief Corp Development Officer

Insider trading activity for Cote Elissa S. sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Corp Development Officer
  • Company: Vistagen Therapeutics, Inc.
  • Total insider trades: 1
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: Apr 9, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Apr 7, 2026 Cote Elissa S. VTGN Vistagen Therapeutics, Inc. BUY 75,000 N/A

← All executives · Full trades feed